BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38425217)

  • 1. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.
    Chen J; Yang Z; Gao F; Zhou Z; Chen J; Lu D; Wang K; Sui M; Wang Z; Guo W; Lyu G; Qi H; Cai J; Yang J; Zheng S; Xu X
    Cancer Biol Med; 2024 Feb; 21(4):347-62. PubMed ID: 38425217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
    Salgia RJ; Goodrich NP; Marrero JA; Volk ML
    Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
    Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
    Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
    Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
    Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recipient obesity does not affect survival after deceased donor liver transplantation for hepatocellular carcinoma. A national retrospective cohort study in the United States.
    Ata N; Ayloo S; Tsung A; Molinari M
    HPB (Oxford); 2019 Jan; 21(1):67-76. PubMed ID: 30691592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.
    Wong TCL; Ng KKC; Fung JYY; Chan AAC; Cheung TT; Chok KSH; Dai JWC; Lo CM
    Ann Surg Oncol; 2019 May; 26(5):1454-1462. PubMed ID: 30737669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
    Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
    Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N; Tanriover B; Singal AG; Marrero JA
    Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors.
    Han S; Yang JD; Sinn DH; Kim JM; Choi GS; Jung G; Ahn JH; Kim S; Ko JS; Gwak MS; Kwon CHD; Leise MD; Gwak GY; Heimbach JK; Kim GS
    Ann Surg; 2018 Dec; 268(6):1043-1050. PubMed ID: 28628564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
    Sharma P; Welch K; Hussain H; Pelletier SJ; Fontana RJ; Marrero J; Merion RM
    Dig Dis Sci; 2012 Mar; 57(3):806-12. PubMed ID: 21953139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
    Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
    Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
    World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Silva JP; Maurina MN; Tsai S; Christians KK; Clarke CN; Mogal H; Saeian K; Gamblin TC
    J Am Coll Surg; 2019 Mar; 228(3):245-254. PubMed ID: 30639515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score.
    Goldberg D; Mantero A; Newcomb C; Delgado C; Forde KA; Kaplan DE; John B; Nuchovich N; Dominguez B; Emanuel E; Reese PP
    J Hepatol; 2021 Jun; 74(6):1398-1406. PubMed ID: 33453328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation.
    Taura K; Shimamura T; Akamatsu N; Umeshita K; Fujiyoshi M; Abe H; Morita S; Uemoto S; Eguchi S; Furukawa H; Takada Y; Egawa H; Ohdan H; Hatano E;
    J Hepatobiliary Pancreat Sci; 2022 May; 29(5):570-584. PubMed ID: 35279950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
    Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of the donor in hepatocellular carcinoma recurrence after liver transplantation.
    Vagefi PA; Dodge JL; Yao FY; Roberts JP
    Liver Transpl; 2015 Feb; 21(2):187-94. PubMed ID: 25371243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.